PURIFICATION AND CHARACTERIZATION OF AN ENDOTHELIN DEGRADATION ENZYME FROM RAT-KIDNEY

被引:16
|
作者
DENG, AY [1 ]
MARTIN, LL [1 ]
BALWIERCZAK, JL [1 ]
JENG, AY [1 ]
机构
[1] CIBA GEIGY CORP,RES DEPT,DIV PHARMACEUT,556 MORRIS AVE,SUMMIT,NJ 07901
来源
JOURNAL OF BIOCHEMISTRY | 1994年 / 115卷 / 01期
关键词
CARBOXYPEPTIDASE; ENDOTHELIN; ENDOTHELIN DEGRADATION ENZYME; PROTEASE;
D O I
10.1093/oxfordjournals.jbchem.a124285
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A soluble protease which effectively inactivated endothelin-1 was purified 2,700-fold from rat kidney using DE52 anion exchange, concanavalin A-Sepharose, thiopropyl-Sepharose, and Mono P column chromatography. The overall recovery of enzyme activity was 12%. This enzyme appeared to contain two subunits with molecular weights of 34 and 21 kDa. The molecular weight of the active enzyme complex was estimated to be 82 kDa by gel filtration. It was shown to have a pI between 4.8 and 5.2 and a pH optimum of 5.5. Its activity was inhibited by benzyloxycarbonyl-Phe-AlaCHN2 and p-hydroxymercuribenzoic acid, thiol protease inhibitors, and by phenylmethylsulfonyl fluoride, a serine protease inhibitor, but not by metalloprotease inhibitors or other serine protease inhibitors. The purified enzyme degraded endothelin-1 rapidly; K(M) and V(max) values were 5.9 muM and 0.40 mumol/mg/min, respectively. It removed the carboxyl terminal tryptophan of endothelin-1 by specifically cleaving the Ile20-Trp21 peptide bond, yielding a peptide which was three orders of magnitude less potent than endothelin-1 in causing contraction of porcine coronary arterial rings. In contrast, proendothelin-1 was not degraded by this enzyme. These results are consistent with published findings that show the clearance rate for proendothelin-1 in the pig to be significantly slower than that for endothelin-1. Our study suggests that this enzyme may play a role in the homeostasis of circulating endothelin-1 and contribute to the regulation of vascular tone.
引用
收藏
页码:120 / 125
页数:6
相关论文
共 50 条
  • [1] PURIFICATION OF ENDOTHELIN-1-INACTIVATING PEPTIDASE FROM THE RAT-KIDNEY
    JANAS, J
    SITKIEWICZ, D
    PULAWSKA, MF
    WARNAWIN, K
    JANAS, RM
    [J]. JOURNAL OF HYPERTENSION, 1994, 12 (04) : 375 - 382
  • [2] PURIFICATION AND CHARACTERIZATION OF GALACTOCEREBROSIDE SULFOTRANSFERASE FROM RAT-KIDNEY
    TENNEKOON, G
    AITCHISON, S
    ZARUBA, M
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 240 (02) : 932 - 944
  • [3] PURIFICATION AND CHARACTERIZATION OF PROTEIN METHYLESTERASE FROM RAT-KIDNEY
    GAGNON, C
    HARBOUR, D
    CAMATO, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1984, 259 (16) : 212 - 215
  • [4] PURIFICATION AND CHARACTERIZATION OF ALKALINE-PHOSPHATASE FROM RAT-KIDNEY
    NOSE, K
    [J]. JOURNAL OF BIOCHEMISTRY, 1976, 79 (02): : 283 - 288
  • [5] PURIFICATION AND CHARACTERIZATION OF A NEW THIOL PROTEINASE FROM RAT-KIDNEY
    GOHDA, E
    PITOT, HC
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 659 (01) : 114 - 122
  • [6] PURIFICATION AND CHARACTERIZATION OF THE ACTIVATED MINERALOCORTICOID RECEPTOR FROM RAT-KIDNEY
    LAZAR, G
    PAGANO, M
    AGARWAL, MK
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY, 1990, 22 (06): : 621 - 630
  • [7] PURIFICATION AND CHARACTERIZATION OF ENDOTHELIN-CONVERTING ENZYME FROM RAT LUNG
    TAKAHASHI, M
    MATSUSHITA, Y
    IIJIMA, Y
    TANZAWA, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (28) : 21394 - 21398
  • [8] PURIFICATION AND CHARACTERIZATION OF PYRUVATE-CARBOXYLASE FROM RAT-KIDNEY CORTEX
    SALTO, R
    LAHOZ, JM
    SOLA, MD
    OLIVER, J
    VARGAS, AM
    [J]. BIOCHEMICAL ARCHIVES, 1990, 6 (04) : 385 - 395
  • [9] PARTIAL-PURIFICATION AND CHARACTERIZATION OF NATRIURETIC FACTOR FROM RAT-KIDNEY
    RAGHAVAN, SRV
    GONICK, HC
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1980, 164 (01): : 101 - 104
  • [10] PURIFICATION AND CHARACTERIZATION OF ENDOTHELIN-1 DEGRADATION ACTIVITY FROM PORCINE KIDNEY
    EDANO, T
    ARAI, K
    OHSHIMA, T
    KOSHI, T
    HIRATA, M
    OHKUCHI, M
    OKABE, T
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1994, 17 (03) : 379 - 382